Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service. Tecan Group AG has a strategic collaboration with NVIDIA Corporation to develop AI-enabled platform for data-driven laboratories to help discoveries and lab productivity. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.
Frequently asked questions
What sector does Tecan Group AG (TECN) operate in?
Tecan Group AG belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is Tecan Group AG (TECN) current stock price?
As of the latest data, Tecan Group AG stock price is CHF 195.00, with a previous close of CHF 179.80. Tecan Group AG gained CHF 15.20 in the last trading session, representing a 8.45% increase.
What is Tecan Group AG (TECN) current market capitalization?
Tecan Group AG market cap is approximately 2.47 billion.
What is Tecan Group AG (TECN) Earnings Per Share (EPS)?
The trailing EPS is -CHF 8.74, and the forward EPS is CHF 7.65.
Does Tecan Group AG (TECN) pay dividends?
Yes. Tecan Group AG pays annual dividends with an annualized yield of 1.54% and an estimated annual payout of CHF 3.00 per share.
When is the next ex-dividend date for Tecan Group AG (TECN)?
The next ex-dividend date is scheduled for April 17, 2027.
When is Tecan Group AG (TECN) next earnings report?
Tecan Group AG is expected to release its next earnings report on June 30, 2026.
What is Tecan Group AG (TECN) beta (volatility) score?
Tecan Group AG has a beta of 1.079, meaning its volatility is roughly in line with the market.
